Lipocine Inc. (LPCN)
$1.66-3.49%Close
SELLCRISIS · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- 0.47
- P/E (TTM)
- -1.12
- Short % float
- 1.73%
- Days to cover
- 2.3
- SI change
- -1.6%
- 1W
- -19.81%
- 1M
- -26.87%
- vs SPY 1W
- -20.23%
- vs SPY 1M
- -28.93%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on LPCN?
- LOPJLB’s latest quantitative signal on Lipocine Inc. (LPCN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LPCN in?
- Lipocine Inc. (LPCN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Lipocine Inc. (LPCN) do?
- Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic conditions. A core aspect of the company's research and development involves formulating oral delivery methods for pharmaceutical compounds that typically suffer from low bioavailability. Its foremost i…